The US FDA = Food and Drug Administration has announced that it will allow additional vaccinations for Moderna and Johnson & Johnson's new coronavirus vaccine to increase efficacy.
We have also newly allowed additional vaccines that are different from the original vaccine.
In the United States, additional vaccinations have been granted to increase the effectiveness of Pfizer's vaccine, which began in September.
The FDA announced on the 20th that it will allow additional vaccinations for the vaccines of American pharmaceutical company Moderna and pharmaceutical giant Johnson & Johnson.
The target of the booster vaccination of Moderna is those who are 65 years old or older, those who are 18 years old or older and have a high risk of aggravation, and those who work in a workplace with a high risk of infection. It is said that a third additional vaccination will be possible after 6 months.
On the other hand, the Johnson & Johnson vaccine, which is given once, is subject to the second booster for all people over the age of 18 who are more than two months old.
In addition, we have newly permitted the additional vaccination of different types of vaccines from the first vaccination.
Dr. Peter Marks, FDA's head of vaccine review, said, "After reviewing the results of clinical trials with different vaccines, we determined that the benefits of additional vaccinations outweigh the risks." I explained.
With the FDA's permission, the CDC Centers for Disease Control and Prevention will make the final decision on whether to recommend booster vaccinations after discussions by a committee of outside experts on the 21st.